Aptamer Group strikes deal with biotech firm for targeted genetic medicine development

Aptamer Group plc (AIM: APTA), a pioneering developer of Optimer binders, has announced a substantial agreement with an undisclosed biotechnology company focused on genetic medicine ... Read More